Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-Severe Asthma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05421598
What this trial is testing

Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma

Who this might be right for
Asthma
Sanofi 437
Not applicableLooking for participantsNCT07709754
What this trial is testing

PULmonary Stimulation for Asthma Relief

Who this might be right for
Moderate to Severe Asthma
Spiro Medical, Inc. 30
Not applicableWithdrawnNCT02347462
What this trial is testing

Bilevel Positive Airway Pressure (BiPAP) for the Treatment of Moderate to Severe Acute Asthma Exacerbations

Who this might be right for
AsthmaStatus Asthmaticus
University of British Columbia
Not applicableUnknownNCT01776177
What this trial is testing

The REALITY Study - a Real-life Long-term Analysis of Xolair Therapy

Who this might be right for
Allergic Asthma
Joseph D. Diaz, MD 240
Not applicableWithdrawnNCT01144910
What this trial is testing

The Long-term Prognosis of Moderate to Severe Bronchial Hyperresponsiveness (BHR) in Asthmatic Preschool Children

Who this might be right for
Intrinsic AsthmaAllergic AsthmaAllergy+1 more
Johann Wolfgang Goethe University Hospital
Testing effectiveness (Phase 2)Study completedNCT04570657
What this trial is testing

Study to Assess the Efficacy and Safety of MEDI3506 in Adults With Uncontrolled Moderate-to-severe Asthma

Who this might be right for
Asthma
AstraZeneca 250
Large-scale testing (Phase 3)Study completedNCT00747318
What this trial is testing

A Phase 3, Multicenter, Open-label Continuation Study in Moderate to Severe Asthmatic Subjects Who Completed FlutiForm HFA pMDI Study SKY2028-3-005

Who this might be right for
Asthma
SkyePharma AG 280
Early research (Phase 1)Study completedNCT02573155
What this trial is testing

Two-part Safety, Tolerability, Pharmacodynamic and -Kinetic Study of Inhaled AZD8871 in Asthmatic and COPD Subjects

Who this might be right for
Asthma (Part 1)COPD (Part 2)
AstraZeneca 134
Testing effectiveness (Phase 2)Study completedNCT01070524
What this trial is testing

Cross-over Study to Evaluate the Effect on Trough Forced Expiratory Volume in One Second (FEV1) After 4 Weeks Treatment With CHF 5188 pMDI qd in Adult Patients With Persistent Asthma

Who this might be right for
Asthma
Chiesi Farmaceutici S.p.A. 113
Testing effectiveness (Phase 2)Study completedNCT05251259
What this trial is testing

Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma

Who this might be right for
Asthma
AstraZeneca 670
Testing effectiveness (Phase 2)UnknownNCT02153541
What this trial is testing

Assessing the Efficacy of CREWS01 to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic Adults

Who this might be right for
Asthma
Global United Pharmaceutical Corporation 50
Not applicableUnknownNCT06771934
What this trial is testing

Combination Therapy of Omalizumab and Allergen Immunotherapy for Moderate to Severe Asthma

Who this might be right for
Allergic Asthma
Qianfoshan Hospital 60
Early research (Phase 1)Study completedNCT04673630
What this trial is testing

Study to Evaluate the Pharmacokinetics of Tezepelumab in Children With Asthma

Who this might be right for
Asthma
AstraZeneca 18
Large-scale testing (Phase 3)Study completedNCT05062759
What this trial is testing

Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With Asthma

Who this might be right for
Moderate to Severe Asthma
AstraZeneca 70
Large-scale testing (Phase 3)Study completedNCT02181335
What this trial is testing

Efficacy and Safety Study Comparing Respimat ® Budesonide With Turbohaler ® Budesonide in Symptomatic Adult Moderate to Severe Asthmatics Requiring Inhaled Corticosteroids and Bronchodilator Therapy

Who this might be right for
Asthma
Boehringer Ingelheim 684
Post-approval studies (Phase 4)Study completedNCT00480649
What this trial is testing

Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone Propionate) Study In Asthma.(SUCCESS)

Who this might be right for
Asthma
GlaxoSmithKline 424
Not applicableUnknownNCT05550402
What this trial is testing

Role of Parasympathetic Activity in Mild to Severe Asthma With Fixed Airway Obstruction (PARASMA Study)

Who this might be right for
AsthmaAirway ObstructionAirway Remodeling+1 more
Hat Yai Medical Education Center 60
Large-scale testing (Phase 3)Study completedNCT04233190
What this trial is testing

A Multicenter, Randomized, Parallel, Two-Period, Non-Inferiority Study of EurofarmavsAlenia in Asthma and COPD Treatment

Who this might be right for
Asthma Copd
Eurofarma Laboratorios S.A. 472
Testing effectiveness (Phase 2)Study completedNCT02367313
What this trial is testing

Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection

Who this might be right for
Asthma
Biota Pharmaceuticals, Inc. 455
Testing effectiveness (Phase 2)Study completedNCT00801307
What this trial is testing

Trial Comparing Effect of He/O2 to Medical Air on Pulmonary Function Disease

Who this might be right for
AsthmaChronic Obstructive Pulmonary DiseaseHealthy
Air Liquide SA 30
Next Page